Bicyclic compound that acts as CRBN protein regulator
US11905276B2 · kind B2 · utility
0Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 14, 2020 |
| Grant date | Feb 20, 2024 |
| Priority date | — |
| Expiry date | Nov 3, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound represented by formula (III) or a pharmaceutically acceptable salt thereof, and disclosed is an application thereof in the preparation of a medication for treating diseases related to a CRBN receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.